Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 9
2003 6
2004 3
2005 6
2006 9
2007 13
2008 5
2009 5
2010 4
2011 4
2012 4
2013 11
2014 8
2015 6
2016 13
2017 14
2018 18
2019 17
2020 27
2021 25
2022 21
2023 19
2024 7

Text availability

Article attribute

Article type

Publication date

Search Results

217 results

Results by year

Filters applied: . Clear all
Page 1
Mpox Neutralizing Antibody Response to LC16m8 Vaccine in Healthy Adults.
Morino E, Mine S, Tomita N, Uemura Y, Shimizu Y, Saito S, Suzuki T, Okumura N, Iwasaki H, Terada J, Ainai A, Sakai Y, Park E, Seki S, Akazawa D, Shimojima M, Shiwa-Sudo N, Virhuez-Mendoza M, Miyauchi K, Moriyama S, Iwata-Yoshikawa N, Harada M, Harada S, Hishiki T, Kotaki R, Matsumura T, Miyamoto S, Kanno T, Isogawa M, Watashi K, Nagata N, Ebihara H, Takahashi Y, Maeda K, Matano T, Wakita T, Suzuki T, Sugiura W, Ohmagari N, Ujiie M. Morino E, et al. Among authors: suzuki t. NEJM Evid. 2024 Mar;3(3):EVIDoa2300290. doi: 10.1056/EVIDoa2300290. Epub 2024 Feb 27. NEJM Evid. 2024. PMID: 38411447
Unfractionated Heparin Safety in COVID-19: Incidence and Risks of Bleeding Complications in Japan.
Sato L, Iwamoto N, Kakumoto Y, Tsuzuki S, Togano T, Ishikane M, Okumura N, Yamada G, Inada M, Suzuki T, Hojo M, Takasaki J, Sasaki R, Kimura A, Teruya K, Okamoto T, Hayakawa K, Hara H, Iseki K, Ohmagari N. Sato L, et al. Among authors: suzuki t. J Atheroscler Thromb. 2024 Feb 14. doi: 10.5551/jat.64448. Online ahead of print. J Atheroscler Thromb. 2024. PMID: 38355124 Free article.
Summary of Research: An Anti-OX40 Antibody to Treat Moderate-to-Severe Atopic Dermatitis: A Multicentre, Double-Blind, Placebo-Controlled Phase 2b Study.
Guttman-Yassky E, Simpson EL, Reich K, Kabashima K, Igawa K, Suzuki T, Mano H, Matsui T, Esfandiari E, Furue M. Guttman-Yassky E, et al. Among authors: suzuki t. Adv Ther. 2024 Mar;41(3):928-931. doi: 10.1007/s12325-023-02755-z. Epub 2024 Jan 8. Adv Ther. 2024. PMID: 38185777 Free PMC article. Clinical Trial.
Real-world effectiveness of full and booster mRNA vaccination for coronavirus disease 2019 against disease severity during the delta- and omicron-dominant phases: A propensity score-matched cohort study using the nationwide registry data in Japan.
Suzuki T, Asai Y, Tsuzuki S, Nomoto H, Matsunaga N, Kodama EN, Hayakawa K, Ohmagari N. Suzuki T, et al. J Microbiol Immunol Infect. 2024 Feb;57(1):20-29. doi: 10.1016/j.jmii.2023.12.002. Epub 2023 Dec 10. J Microbiol Immunol Infect. 2024. PMID: 38123439 Free article.
Efficacy and viral dynamics of tecovirimat in patients with MPOX: A multicenter open-label, double-arm trial in Japan.
Akiyama Y, Morioka S, Tsuzuki S, Yoshikawa T, Yamato M, Nakamura H, Shimojima M, Takakusaki M, Saito S, Takahashi K, Sanada M, Komatsubara M, Takebuchi K, Yamaguchi E, Suzuki T, Shimokawa K, Kurosu T, Kawahara M, Oishi K, Ebihara H, Ohmagari N. Akiyama Y, et al. Among authors: suzuki t. J Infect Chemother. 2024 Jun;30(6):488-493. doi: 10.1016/j.jiac.2023.11.025. Epub 2023 Nov 30. J Infect Chemother. 2024. PMID: 38042298 Free article. Clinical Trial.
Trends of participants in convalescent plasma donation for COVID-19 in Japan as the pandemic evolved.
Suzuki T, Asai Y, Takahashi K, Sanada M, Shimanishi Y, Terada M, Sato L, Inada M, Yamada G, Akiyama Y, Oshiro Y, Shiratori K, Togano T, Takamatsu Y, Kenji M, Matsunaga A, Ishizaka Y, Nomoto H, Iwamoto N, Saito S, Kutsuna S, Morioka S, Ohmagari N. Suzuki T, et al. Heliyon. 2023 Sep 29;9(10):e20568. doi: 10.1016/j.heliyon.2023.e20568. eCollection 2023 Oct. Heliyon. 2023. PMID: 37842585 Free PMC article.
An open-label, non-randomized study investigating the safety and efficacy of smallpox vaccine, LC16, as post-exposure prophylaxis for mpox.
Tomita N, Terada-Hirashima J, Uemura Y, Shimizu Y, Iwasaki H, Yano R, Suzuki T, Saito S, Okumura N, Sugiura W, Ohmagari N, Ujiie M. Tomita N, et al. Among authors: suzuki t. Hum Vaccin Immunother. 2023 Aug 1;19(2):2242219. doi: 10.1080/21645515.2023.2242219. Hum Vaccin Immunother. 2023. PMID: 37559375 Free PMC article. Clinical Trial.
217 results